Oppenheimer Asset Management’s Immunocore IMCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $221K | Sell |
7,035
-539
| -7% | -$16.9K | ﹤0.01% | 1066 |
|
|
2025
Q1 | $225K | Buy |
+7,574
| New | +$225K | ﹤0.01% | 1026 |
|
|
2024
Q4 | – | Sell |
-8,045
| Closed | -$250K | – | 1174 |
|
|
2024
Q3 | $250K | Sell |
8,045
-118
| -1% | -$3.67K | ﹤0.01% | 1040 |
|
|
2024
Q2 | $277K | Buy |
8,163
+43
| +0.5% | +$1.46K | ﹤0.01% | 996 |
|
|
2024
Q1 | $528K | Sell |
8,120
-131
| -2% | -$8.52K | 0.01% | 820 |
|
|
2023
Q4 | $564K | Buy |
8,251
+760
| +10% | +$51.9K | 0.01% | 841 |
|
|
2023
Q3 | $389K | Buy |
7,491
+1,572
| +27% | +$81.6K | 0.01% | 905 |
|
|
2023
Q2 | $355K | Buy |
+5,919
| New | +$355K | 0.01% | 938 |
|